Fundraising FoxFuture Ventures — 2025 Investments
9 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)inOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitaliSelect FundS2G InvestmentsAgFunder+7 more
BMC Ingredients produces Rhiza, a mycelium-based ingredient that serves as a whole-food, complete protein and clean-label additive for food manufacturers.
BiotechClimate TechFoodTechNew MaterialsWest Sacramento, US
Paul Shapiro(Co-founder & CEO)inNikhil Prashar(CFO)inMoran Farhi(EVP of Tech)inAndrea Choe(SVP of Ops)Stu Strumwasser(Director)Brian Ottens(Director)
Board seatSteve Jurvetson· per SEC Form D
Co-investorsEvolution VC PartnersGreen Circle Foodtech VenturesLever VCEPIC VENTURES
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR.
BiotechHealthtechLongevityNew York, US
James Peyer(CEO, Founder, Board Director)inMark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inBill DeVaul(Chief Legal Officer)in
BoardChristian Angermayer(Chairman, Co-Founder, Board Director)in
Board seatMaryanna Saenko· per SEC Form D
Co-investorsAlumni VenturesCatalio Capital Management, LPFJ LabsKhosla VenturesKorify CapitalSprint Vc+4 more
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.
BiotechFemTechHealthtechMedical DevicesAustin, US
Dina Turner(Co-founder & Chief Executive Officer)inMartin Varsavsky(Co-founder & Chairman)inDina Radenkovic(Founder)inMartín Varsavsky(Founder)
BoardDusan Perovic(Director)inDylan Morris(Director)in
Board seatMaryanna Saenko· per SEC Form D
Co-investorsBold Capital PartnersDeviation CapitalFJ LabsGaingelsIngeborg InvestmentsInsight Partners+19 more
__Twitter.png)
Realta Fusion develops fusion energy technology to generate zero-carbon electricity and industrial process heat for global use.
CleantechDeep TechEnergyMadison, US
Kieran Furlong(Founder)inCary Forest(Founder)inJay Anderson(Founder)inBen Lindley(Founder)inOliver Schmitz(Co-Founder, Plasma Facing Components)in
Board seatMaryanna Saenko· per SEC Form D · $35.5M raise · filed May 2025
Co-investorsAlumni VenturesAvilaKhosla VenturesOctave Ventures LlcTitletownTechBaruch Future Ventures
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
BiotechHealthtech
Jacob Glanville(Founder)inStephanie Wisner(Founder)in
Co-investorsAmplify PartnersBold Capital PartnersGlobal Health Investment CorporationKendall Capital PartnersNFX
Commonwealth (commonwealth.im) is a DAO coordination platform; the sources supplied contain no verifiable information about it.
Co-investorsCanaan PartnersCoinbase VenturesIOSG VenturesNascentBreakthrough Energy VenturesGalaxy Interactive+9 more
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in
Co-investorsDevice of Tomorrow CapitalDolby Family VenturesEmpath VenturesGreyMatterMana VenturesPioneer+4 more
Unconventional AI develops energy-efficient computing architectures for AI systems by applying biological principles and analog circuit design to optimize performance.
AI & Machine LearningDeep TechHardwareSan Diego, US
Naveen Rao(Founder)inMeeLan Lee(Founder)inMichael Carbin(Founder)inMike Carbin(Founder)Sara Achour(Founder)
Co-investorsAndreessen HorowitzDataPower VenturesDCVC (Data Collective)Decibel PartnersEniac VenturesEval Ventures Fund+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.